Inclusion of diabetic retinopathy screening strategies in national-level diabetes care planning in low- and middle-income countries: a scoping review.

Katie Curran, Prabhath Piyasena, Nathan Congdon, Lisa Duke, Belma Malanda, Tunde Peto

Journal: Health research policy and systems 2023;21(1):2

PMID: 36593508

Abstract

BACKGROUND

Diabetes is a major public health concern, with approximately 80% of the burden falling on low- and middle-income countries (LMICs). Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes, and early detection through diabetic eye screening programmes is essential to prevent visual impairment and blindness. Careful planning at a national level is crucial for effective implementation of such programmes.

METHODS

A scoping review was conducted, and the protocol was published previously to explain the methods in detail. Data were collected from databases and searches, including grey literature. Furthermore, consultations were conducted with key informants from LMICs.

RESULTS

Lower-middle-income countries (29/50, 58%) and upper-middle-income countries (27/59, 45.8%) are making more progress than low-income countries (4/29, 13.8%) in terms of DR policy planning. However, no identified data for published policies have actually implemented national DR policies. Compared to low-income and lower-middle-income countries, upper-middle-income countries are making the most progress in implementing national diabetic eye screening programmes; however, their progress is still slow, with only 5/59 (8.5%) having such programmes.

CONCLUSION

There are significant gaps in the literature, with no data reported for 78/138 (56.5%) LMICs. Further research is clearly needed to support and document DR policy development in LMICs.

© 2022. The Author(s).

Address: Centre for Public Health, Institute of Clinical Science, Queen's University Belfast, Block A, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland, UK. [email protected].; Centre for Public Health, Institute of Clinical Science, Queen's University Belfast, Block A, Royal Victoria Hospital, Belfast, BT12 6BA, Northern Ireland, UK.; Directorate of Policy Analysis and Development, Ministry of Health, Columbo, Sri Lanka.; Zhongshan Ophthalmic Centre, Sun Yat-Sen University, Guangzhou, China.; Orbis International, New York, USA.; International Diabetes Federation, Brussels, Belgium.; Department of Ophthalmology, Belfast Health and Social Care Trust, Belfast, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.